open access
Oesophageal cancer — case report and literature review
Affiliations
- Department of Clinical Oncology, University Clinical Centre named after Prof. K. Gibiński in Katowice, Poland
open access
Abstract
Based on the case report in this article, the different means of effective treatment, both causative and palliative, including available therapeutic modalities (radio-chemotherapy, chemotherapy) of locally advanced and subsequently metastatic squamous cell carcinoma of the cervical oesophagus, are presented. Despite a very long period between diagnosis and initiation of the treatment, satisfactory disease control and overall survival were achieved.
Abstract
Based on the case report in this article, the different means of effective treatment, both causative and palliative, including available therapeutic modalities (radio-chemotherapy, chemotherapy) of locally advanced and subsequently metastatic squamous cell carcinoma of the cervical oesophagus, are presented. Despite a very long period between diagnosis and initiation of the treatment, satisfactory disease control and overall survival were achieved.
Keywords
squamous cell carcinoma of the cervical oesophagus, management strategy, available therapeutic modalities (radio-chemotherapy, chemotherapy)
About this articleTitle
Oesophageal cancer — case report and literature review
Journal
Issue
Article type
Case report
Pages
30-33
Published online
2017-07-21
DOI
10.5603/OCP.2017.0005
Bibliographic record
Oncol Clin Pract 2017;13(1):30-33.
Keywords
squamous cell carcinoma of the cervical oesophagus
management strategy
available therapeutic modalities (radio-chemotherapy
chemotherapy)
Authors
Marek Kowalczyk
Michał Piątek
Dorota Imielska Zdunek
Agnieszka Boratyn-Nowicka
References (12)- Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii — Instytut im. Marii Skłodowskiej-Curie. Available on http://onkologia.org. pl/raporty/last access on 22. ; 05: 2017.
- Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013; 381(9864): 400–412.
- Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25(10): 1160–1168.
- Gaast AV, Hagen Pv, Hulshof M, et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. Journal of Clinical Oncology. 2010; 28(15_suppl): 4004–4004.
- Sjoquist KM, Burmeister BH, Smithers BM, et al. Australasian Gastro-Intestinal Trials Group, Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007; 8(3): 226–234.
- Jin HL, Zhu H, Ling TS, et al. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol. 2009; 15(47): 5983–5991.
- Akutsu, Y. & Matsubara, H. Chemoradiotherapy and surgery for T4 esophageal cancer in Japan Surg Today. 2015; 45: 1360.
- Sabra MJ, Smotherman C, Kraemer DF, et al. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012. J Surg Oncol. 2017; 115(3): 296–300.
- Schreiber D, Rineer J, Vongtama D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol. 2010; 5(2): 244–250.
- Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001; 345(10): 725–730.
- Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005; 23(10): 2310–2317.
- Homs MYV, v d Gaast A, Siersema PD, et al. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction. Cochrane Database Syst Rev. 2006(4): CD004063.